In the latest session, Exelixis Inc (NASDAQ: EXEL) closed at $22.65 down -4.35% from its previous closing price of $23.68. In other words, the price has decreased by -$1.03 from its previous closing price. On the day, 2357426 shares were traded.
Ratios:
For a deeper understanding of Exelixis Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.90 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 23.45. For the most recent quarter (mrq), Quick Ratio is recorded 3.30 and its Current Ratio is at 3.34. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.08.
On December 19, 2023, BTIG Research started tracking the stock assigning a Buy rating and target price of $27.
On December 15, 2023, Citigroup started tracking the stock assigning a Buy rating and target price of $31.Citigroup initiated its Buy rating on December 15, 2023, with a $31 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 21 ’24 when Garber Alan M sold 19,205 shares for $24.01 per share. The transaction valued at 461,112 led to the insider holds 35,703 shares of the business.
Haley Patrick J. sold 47,020 shares of EXEL for $1,008,579 on Feb 23 ’24. The EVP, Commercial now owns 384,866 shares after completing the transaction at $21.45 per share. On Feb 21 ’24, another insider, JOHNSON DAVID EDWARD, who serves as the Director of the company, bought 190,000 shares for $20.70 each. As a result, the insider paid 3,932,734 and bolstered with 1,100,730 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EXEL now has a Market Capitalization of 6.87B and an Enterprise Value of 6.06B. As of this moment, Exelixis’s Price-to-Earnings (P/E) ratio for their current fiscal year is 35.00, and their Forward P/E ratio for the next fiscal year is 14.62. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.84. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.75 while its Price-to-Book (P/B) ratio in mrq is 3.03. Its current Enterprise Value per Revenue stands at 3.31 whereas that against EBITDA is 30.83.
Stock Price History:
Over the past 52 weeks, EXEL has reached a high of $24.34, while it has fallen to a 52-week low of $18.08. The 50-Day Moving Average of the stock is 22.26, while the 200-Day Moving Average is calculated to be 21.65.
Shares Statistics:
For the past three months, EXEL has traded an average of 2.24M shares per day and 2.01M over the past ten days. A total of 302.79M shares are outstanding, with a floating share count of 294.81M. Insiders hold about 2.76% of the company’s shares, while institutions hold 87.31% stake in the company. Shares short for EXEL as of Mar 28, 2024 were 6.83M with a Short Ratio of 3.04, compared to 8.85M on Feb 29, 2024. Therefore, it implies a Short% of Shares Outstanding of 2.25% and a Short% of Float of 2.59%.
Earnings Estimates
There are 14 different market analysts currently analyzing its stock. On average, analysts expect EPS of $0.24 for the current quarter, with a high estimate of $0.47 and a low estimate of $0.11, while EPS last year was $0.12. The consensus estimate for the next quarter is $0.31, with high estimates of $0.42 and low estimates of $0.19.
Analysts are recommending an EPS of between $1.36 and $1.04 for the fiscal current year, implying an average EPS of $1.23. EPS for the following year is $1.46, with 15 analysts recommending between $2.07 and $1.1.
Revenue Estimates
A total of 17 analysts believe the company’s revenue will be $454.43M this quarter.It ranges from a high estimate of $521M to a low estimate of $409.2M. As of the current estimate, Exelixis Inc’s year-ago sales were $408.79M, an estimated increase of 11.20% from the year-ago figure. For the next quarter, 17 analysts are estimating revenue of $477.88M, an increase of 1.70% less than the figure of $11.20% in the same quarter last year. There is a high estimate of $547M for the next quarter, whereas the lowest estimate is $450M.
A total of 21 analysts have provided revenue estimates for EXEL’s current fiscal year. The highest revenue estimate was $1.97B, while the lowest revenue estimate was $1.83B, resulting in an average revenue estimate of $1.9B. In the same quarter a year ago, actual revenue was $1.83B, up 4.00% from the average estimate. Based on 19 analysts’ estimates, the company’s revenue will be $2.06B in the next fiscal year. The high estimate is $2.26B and the low estimate is $1.91B. The average revenue growth estimate for next year is up 8.40% from the average revenue estimate for this year.
